← Leaderboards
Semanti Mukherjee
Feinstein Institute For Medical Research
$2,979,370
Attributed
$2,979,370
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $719.7K · FY2013–25$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,979,370 · 2
By mechanism
R37$2,799,371 · 1
K99$179,999 · 1
Top collaborators
No co-investigators on record.
Most similar at Feinstein Institute For Medical Research
Same institution · by research overlap
- Todd Lencz$13,113,988
- Ariel Darvasi$1,262,956
- Yun Freudenberg-Hua$739,344
Others in their field
Top investigators on “Technology”
- David Heimbrook · Leidos Biomedical Research, Inc.$995,338,451
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Eric S Lander · Whitehead Institute For Biomedical Res$606,570,095
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Richard K. Wilson · Washington University$441,856,657
Research focus
TechnologyGenomicsGenome Wide Association StudySamplingCase ControlGenotypeEtiologyGenome SequencingMutationPredispositionAlgorithmsVariantNext Generation SequencingBiologicalCohortDiagnosisGenesGeneticBrca GeneBrca2 GeneArchitectureChemotherapyCigarette SmokingClinically Actionable
Grant awards (6)
Discovery and characterization of clinically actionable germline mutations in DNA damage repair (DDR) pathway genes in lung cancer$697,654
R37 · FY2025 · CA · contact PI
Discovery and characterization of clinically actionable germline mutations in DNA damage repair (DDR) pathway genes in lung cancer$676,729
R37 · FY2024 · CA · contact PI
Discovery and characterization of clinically actionable germline mutations in DNA damage repair (DDR) pathway genes in lung cancer$705,297
R37 · FY2023 · CA · contact PI
Discovery and characterization of clinically actionable germline mutations in DNA damage repair (DDR) pathway genes in lung cancer$719,691
R37 · FY2022 · CA · contact PI
Identifying Schizophrenia Risk Loci in the MHC Using Next Generation Sequencing$89,999
K99 · FY2014 · MH · contact PI
Identifying Schizophrenia Risk Loci in the MHC Using Next Generation Sequencing$90,000
K99 · FY2013 · MH · contact PI